Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial ; volume:15 ; number:1 ; day:12 ; month:1 ; year:2024 ; pages:1-12 ; date:12.2024
Nature Communications ; 15, Heft 1 (12.1.2024), 1-12, 12.2024
- Creator
-
Galanis, Evanthia
Dooley, Katharine E.
Keith Anderson, S.
Kurokawa, Cheyne B.
Carrero, Xiomara W.
Uhm, Joon H.
Federspiel, Mark J.
Leontovich, Alexey A.
Aderca, Ileana
Viker, Kimberly B.
Hammack, Julie E.
Marks, Randolph S.
Robinson, Steven I.
Johnson, Derek R.
Kaufmann, Timothy J.
Buckner, Jan C.
Lachance, Daniel H.
Burns, Terry C.
Giannini, Caterina
Raghunathan, Aditya
Iankov, Ianko D.
Parney, Ian F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-43076-7
- URN
-
urn:nbn:de:101:1-2024032515384849884057
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Galanis, Evanthia
- Dooley, Katharine E.
- Keith Anderson, S.
- Kurokawa, Cheyne B.
- Carrero, Xiomara W.
- Uhm, Joon H.
- Federspiel, Mark J.
- Leontovich, Alexey A.
- Aderca, Ileana
- Viker, Kimberly B.
- Hammack, Julie E.
- Marks, Randolph S.
- Robinson, Steven I.
- Johnson, Derek R.
- Kaufmann, Timothy J.
- Buckner, Jan C.
- Lachance, Daniel H.
- Burns, Terry C.
- Giannini, Caterina
- Raghunathan, Aditya
- Iankov, Ianko D.
- Parney, Ian F.
- SpringerLink (Online service)
Other Objects (12)
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma